logo

DermNet NZ


Facts about the skin from DermNet New Zealand Trust. Topic index: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Confluent and reticulated papillomatosis

Confluent and reticulated papillomatosis (CRP) is also known as Gougerot-Carteaud Syndrome. Gourgerot and Carteaud originally described the condition in 1927.

What is confluent and reticulated papillomatosis?

CRP is a rare skin disease characterised by:

Confluent and reticulated papillomatosis
Confluent and reticulated papillomatosis

The condition is more common in young women than in men (except in Japan where the reverse is true) and usually starts soon after puberty. The condition is chronic with exacerbations and remissions. In some cases, after spreading slowly for a few years, the lesions remain permanently unchanged and cause no symptoms.

What is the cause of confluent and reticulated papillomatosis?

The cause of CRP is unknown. Several possible causes have been suggested and include:

1. Natarajan S, Milne D, Jones AL, Goodfellow M, Perry J, Koerner RJ. Dietzia strain xL a newly described Actinomycete isolated from confluent and reticulated papillomatosis. British Journal of Dermatology 2005; 153: 825-827

What is the treatment for confluent and reticulated papillomatosis?

CRP is a benign skin disorder that results in cosmetic disfigurement. As mentioned earlier it is a chronic disorder with exacerbations and remissions. Several therapies have been used in an attempt to clear the condition and prevent it from recurring.

Discontinuation of successful treatment may result in a recurrence of the condition.

Related information

References:

On DermNet NZ:

Other websites:

Books about skin diseases:

See the DermNet NZ bookstore

Author: Vanessa Ngan, staff writer

DermNet NZ does not provide an on-line consultation service.
If you have any concerns with your skin or its treatment, see a dermatologist for advice.